FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1572147296> ?p ?o ?g. }

• W1572147296 endingPage "314" @default.
• W1572147296 startingPage "309" @default.
• W1572147296 abstract "Introduction: Multiple pharmacological therapies currently in prevalent clinical use for cardiac diseases have antifibrotic properties. Spironolactone, a potent antifibrotic agent, is currently used for advanced heart failure. Therapies such as HMG-CoA reductase inhibitors (statins) and angiotensin-converting enzyme inhibitors (ACEi) also have antifibrotic properties. However, the effect of these medications on the ventricular arrhythmia phenotype is currently unknown. Therefore, we set out to define the ventricular arrhythmia rates in patients actively treated with such therapies. Methods and Results: We retrospectively evaluated the ventricular tachycardia (VT) rates in patients with structural heart disease actively treated with therapies with antifibrotic properties. VT rates were significantly diminished in patients treated with spironolactone (158 ± 26 beats per minute [bpm], n = 21) compared to patients on no medications (205 ± 22 bpm, n = 13) or those who were on similar heart-failure therapies but not on spironolactone (186 ± 32 bpm, n = 82). In addition, we observed that VT rates showed a significant trend toward lower rates in patients receiving either statins or ACEi, compared to patients on no medical therapy. In multivariate analysis, spironolactone therapy was identified as the single most significant variable for reduced VT rate. Conclusion: Use of spironolactone in patients with heart failure is associated with reduced VT rate. Similar but less-significant reductions in VT rates were observed with use of other pharmacological agents with antifibrotic properties, such as statins and ACEi. Our findings, at least in part, could account for reduction in sudden cardiac death rates documented with use of these therapies. (PACE 2011; 34:309–314))" @default.
• W1572147296 created "2016-06-24" @default.
• W1572147296 creator A5012700139 @default.
• W1572147296 creator A5038992662 @default.
• W1572147296 creator A5047742063 @default.
• W1572147296 creator A5063818701 @default.
• W1572147296 creator A5077418788 @default.
• W1572147296 creator A5081821816 @default.
• W1572147296 date "2010-10-14" @default.
• W1572147296 modified "2023-09-27" @default.
• W1572147296 title "Spironolactone Therapy is Associated with Reduced Ventricular Tachycardia Rate in Patients with Cardiomyopathy" @default.
• W1572147296 cites W1965355671 @default.
• W1572147296 cites W1965380680 @default.
• W1572147296 cites W1995354197 @default.
• W1572147296 cites W1998955714 @default.
• W1572147296 cites W2016847442 @default.
• W1572147296 cites W2022153462 @default.
• W1572147296 cites W2052109913 @default.
• W1572147296 cites W2054758759 @default.
• W1572147296 cites W2062445874 @default.
• W1572147296 cites W2063351443 @default.
• W1572147296 cites W2073084507 @default.
• W1572147296 cites W2073420780 @default.
• W1572147296 cites W2074992357 @default.
• W1572147296 cites W2076365943 @default.
• W1572147296 cites W2079399685 @default.
• W1572147296 cites W2104793759 @default.
• W1572147296 cites W2106493153 @default.
• W1572147296 cites W2109619277 @default.
• W1572147296 cites W2116965334 @default.
• W1572147296 cites W2128261880 @default.
• W1572147296 cites W2129328611 @default.
• W1572147296 cites W2140739392 @default.
• W1572147296 cites W2148075660 @default.
• W1572147296 cites W2152108583 @default.
• W1572147296 cites W2161918376 @default.
• W1572147296 cites W2169804106 @default.
• W1572147296 cites W2323458614 @default.
• W1572147296 cites W2337042699 @default.
• W1572147296 cites W4232767515 @default.
• W1572147296 doi "https://doi.org/10.1111/j.1540-8159.2010.02888.x" @default.
• W1572147296 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3617503" @default.
• W1572147296 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20946289" @default.
• W1572147296 hasPublicationYear "2010" @default.
• W1572147296 type Work @default.
• W1572147296 sameAs 1572147296 @default.
• W1572147296 citedByCount "8" @default.
• W1572147296 countsByYear W15721472962012 @default.
• W1572147296 countsByYear W15721472962013 @default.
• W1572147296 countsByYear W15721472962015 @default.
• W1572147296 countsByYear W15721472962017 @default.
• W1572147296 countsByYear W15721472962019 @default.
• W1572147296 countsByYear W15721472962023 @default.
• W1572147296 crossrefType "journal-article" @default.
• W1572147296 hasAuthorship W1572147296A5012700139 @default.
• W1572147296 hasAuthorship W1572147296A5038992662 @default.
• W1572147296 hasAuthorship W1572147296A5047742063 @default.
• W1572147296 hasAuthorship W1572147296A5063818701 @default.
• W1572147296 hasAuthorship W1572147296A5077418788 @default.
• W1572147296 hasAuthorship W1572147296A5081821816 @default.
• W1572147296 hasBestOaLocation W15721472962 @default.
• W1572147296 hasConcept C126322002 @default.
• W1572147296 hasConcept C164705383 @default.
• W1572147296 hasConcept C2776331378 @default.
• W1572147296 hasConcept C2776379505 @default.
• W1572147296 hasConcept C2776934708 @default.
• W1572147296 hasConcept C2777953023 @default.
• W1572147296 hasConcept C2778198053 @default.
• W1572147296 hasConcept C2778797674 @default.
• W1572147296 hasConcept C2779167562 @default.
• W1572147296 hasConcept C2780283014 @default.
• W1572147296 hasConcept C71924100 @default.
• W1572147296 hasConcept C84393581 @default.
• W1572147296 hasConceptScore W1572147296C126322002 @default.
• W1572147296 hasConceptScore W1572147296C164705383 @default.
• W1572147296 hasConceptScore W1572147296C2776331378 @default.
• W1572147296 hasConceptScore W1572147296C2776379505 @default.
• W1572147296 hasConceptScore W1572147296C2776934708 @default.
• W1572147296 hasConceptScore W1572147296C2777953023 @default.
• W1572147296 hasConceptScore W1572147296C2778198053 @default.
• W1572147296 hasConceptScore W1572147296C2778797674 @default.
• W1572147296 hasConceptScore W1572147296C2779167562 @default.
• W1572147296 hasConceptScore W1572147296C2780283014 @default.
• W1572147296 hasConceptScore W1572147296C71924100 @default.
• W1572147296 hasConceptScore W1572147296C84393581 @default.
• W1572147296 hasIssue "3" @default.
• W1572147296 hasLocation W15721472961 @default.
• W1572147296 hasLocation W15721472962 @default.
• W1572147296 hasLocation W15721472963 @default.
• W1572147296 hasLocation W15721472964 @default.
• W1572147296 hasOpenAccess W1572147296 @default.
• W1572147296 hasPrimaryLocation W15721472961 @default.
• W1572147296 hasRelatedWork W123522969 @default.
• W1572147296 hasRelatedWork W1834116315 @default.
• W1572147296 hasRelatedWork W2047274607 @default.
• W1572147296 hasRelatedWork W2110989758 @default.
• W1572147296 hasRelatedWork W2140392144 @default.
• W1572147296 hasRelatedWork W2202497401 @default.

• next